Abstract:To investigate the associated biomolecular mechanisms of intratumoral RFH- enhanced local HSV-TK/ ganciclovir (GCV)-mediated suicide gene therapy of rat orthotopic lung cancers. Human lung cancer cells (A549) transduced with Luciferase/mCherry/lentivirus and 24 nude rats with orthotopic lung cancers were divided into four study groups with treatments of (i) intratumoral HSV-TK/GCV gene therapy followed by RFH at 41-42 °C for 30 minutes; (ii) HSV-TK/GCV therapy alone; (iii) RFH alone; (iv) PBS as a control. Flow cytometry, bioluminescence assay and confocal microscopy were used to determine the apoptosis and viability of cells. Bioluminescence optical imaging was used to evaluate the changes of bioluminescent signals among the groups over 2 weeks. The expression of Bcl-2/Bax, Caspase-3 and HSP70 in both cells and tumor tissue were quantified by western blotting (WB) and immunohistochemistical (IHC) staining respectively. Compared with gene therapy alone, RFH alone or PBS, combination therapy induced the lowest cell viability (30.56 ± 9.12% VS 65.47 ± 8.02% VS 89.95 ± 6.33% VS 100% P<0.05), the highest cell apoptosis (20.05 ± 2.12% VS 9.87 ± 2.02% VS 4.31 ± 4.31% VS 3.12 ± 1.03%, P<0.05), and a remarkable decrease of relative bioluminescence signal (16.54 ± 0.12% VS 54.8 ± 0.10% VS 85.01 ± 0.08% VS 100%, P<0.01). Optical imaging showed a markedly decreased bioluminescence signal of the tumor in combination therapy (1.29 ± 0.18 VS 1.76 ± 0.13 VS 2.26 ± 0.17 VS 2.94 ± 0.15, P<0.05). Both WB analysis and IHC staining displayed the significantly decreased expression of Bcl-2 (1.03 ± 0.28 VS 2.15 ± 0.33 VS 3.48 ± 0.12 VS 3.87 ± 0.17×107 IOD, P<0.01), as well as increased expression of Bax (3.30 ± 0.0.36 VS 2.02 ± 0.20 VS 1.48 ± 0.31 VS 1.26 ± 0.07, 107 IOD, P<0.01), Caspase-3 (5.58 ± 0.52 VS 3.36 ± 0.29 VS 1.42 ± 0.34VS 1.21 ± 0.52, 107 IOD, P<0.05) and HSP70 (8.79 ± 0.62 VS 3.97 ± 0.31 VS 4.48 ± 0.42 VS 1.60 ± 0.23, 107 IOD, P<0.01) in cancer tissues of combination therapy group. Intratumoral RFH-enhanced suicide gene therapy on rat orthotopic lung cancers through the mechanisms of augmenting apoptosis and the expression of HSP-70 pathway, which may provide additional insights to further improving treatment of lung cancers.

Research Progress of a Novel Pro-apoptosis Gene PNAS-4 in Gene Therapy and Its Molecular Mechanism Hypotheses

A Novel Pro-Apoptosis Gene Pnas4 That Induces Apoptosis in A549 Human Lung Adenocarcinoma Cells and Inhibits Tumor Growth in Mice

PNAS-4, a Novel Pro-Apoptotic Gene, Can Potentiate Antineoplastic Effects of Cisplatin

Improved Therapeutic Efficacy Against Murine Carcinoma By Combining Honokiol With Gene Therapy Of Pnas-4, A Novel Pro-Apoptotic Gene

PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells

PNAS-2: a novel gene probably participating in leukemogenesis.

Research Advancement on the Molecular Mechanism of Par-4 Induced Apoptosis

Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model

Pnas-4 Expression and Its Relationship to P53 in Colorectal Cancer

Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer.

Altered Protein-Expressing Profile in Hpnas4-Induced Apoptosis in A549 Human Lung Adenocarcinoma Cells

[Construction and Expression of Eukaryotic Expression Vector of a Novel Apoptosis-Related Mouse Gene, Mpnas-4 and Its Antitumor Activity in Vitro].

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells

Advancements in p53-Based Anti-Tumor Gene Therapy Research

Nanomaterials-Induced PANoptosis: A Promising Anti-Tumor Strategy.

Small molecules targeting tumor apoptosis related proteins and genes

A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.

Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy

Cancer Gene Therapy Targeting Cellular Apoptosis Machinery

PAR-4: a possible new target for age-related disease.